“Black” patients had lower pCR rates for triple-negative and HR−/ERBB2+ breast cancer but higher pCR rates for HR+/ERBB2− breast cancer, whereas “Asians” and “Pacific Islanders” exhibited higher pCR rates for HR−/ERBB2+ malignancies. Here, ERBB2 is linked to breast cancer.